Plum SEC
Menu
Korean Market
Privacy Policy
Korean Market
Star Rating
Reset (View All)
★★★★★
★★★★
★★★
★★
★
★
★
★★
★★★
★★★★
★★★★★
All Disclosures
Search
EXCH
Kolon TissueGene
★★
Derivative Valuation Loss of 94.9 Billion Won, 42.73% of Equity
05/15/2026, 05:20 PM
OWNR
Kolon TissueGene
★
Kolon Increases Share Count via Exchangeable Bond Conversion
05/15/2026, 05:06 PM
PERI
Kolon TissueGene
★
Kolon TissueGene Q1 2026: Phase 3 Trial on Track, Net Loss Swells Due to Large Derivative Valuation Loss
05/15/2026, 04:30 PM